Sun Pharma settles litigation with Incyte Corp over hair loss drug Leqselvi
Sun Pharmaceutical Industries has reached a settlement agreement with Incyte Corporation concerning Leqselvi, a drug for severe hair loss, leading to the dismissal of pending litigation in the US. Incyte has granted Sun a non-exclusive license for oral deuruxolitinib for specific non-oncology indications, including alopecia areata, in the US.
Reuters Sun pharma logo( File photo) Sun Pharmaceutical Industries on Monday said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for severe hair loss.Under the terms of agreement, the parties will seek dismissal of the pending Leqselvi litigation in the US District Court for the District of New Jersey, and Sun and Incyte will mutually release each other of all claims that were raised or could have been raised in that litigation, the Mumbai-based drug major said in a statement.
As a part of the agreement, Incyte has granted to Sun a limited, non-exclusive license to US Patent Nos. 9,662,335 and certain other related patents with respect to oral deuruxolitinib for certain agreed-upon non-hematology-oncology indications, including alopecia areata, in the US, it added.
Sun will pay Incyte an upfront amount, plus ongoing royalty payments until the expiry of the patents, in exchange for the settlement and license, it stated. Other specific terms of the settlement and license agreement are confidential, it added.
In a separate statement, the drug firm announced the launch of Leqselvi (8 mg) tablets in the US market.The medication (deuruxolitinib) is indicated for the treatment of adults with severe alopecia areata."The launch of Leqselvi in the US brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," Richard Ascroft, CEO of Sun Pharma North America, said."As a company committed to launching new therapeutic options which address the unmet needs of patients, adding Leqselvi to our dermatology portfolio represents a key milestone for the business and an important advancement for the alopecia areata community," he added.
Shares of Sun Pharma ended 0.54 per cent higher at Rs 1,681.45 apiece on the BSE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 minutes ago
- Time of India
FD rate falling: Seniors can still earn 8.2% interest with this post office scheme
Academy Empower your mind, elevate your skills SCSS interest rate Banks offering high FD interest rates: SCSS tax details SCSS account closure details With interest rates on fixed deposits (FDs) declining following the 1% repo rate by the Reserve Bank of India (RBI) since February, the Senior Citizen Savings Scheme (SCSS), which is backed by the Government of India, stands out as a good alternative, as it is risk-free and offers higher interest income and tax benefits under 80C, making it suitable especially for senior citizens seeking stable government of India revises the interest rate on SCSS along with other small savings schemes every quarter. Recently, it announced the interest rates on SCSS applicable for the July-September quarter of FY to the government's announcement, there were no changes in the interest rates for small savings schemes like Public Provident Fund (PPF), National Savings Scheme (NSC), Senior Citizen Savings Scheme (SCSS), and read: Has Govt cut PPF, NSC interest rate after RBI repo rate cut of 1%? Check the latest interest rate of post office schemes announced today "The rates of interest on various small savings schemes for the second quarter of FY 2025-26, starting from 1st July 2025 and ending on 30th September 2025, shall remain unchanged from those notified for the first quarter (1st April 2025 to 30th June 2025) of FY 2025-26," the Ministry of Finance said in a circular on June 30, offers a quarterly interest payout at an annual rate of 8.2%, whereas FD interest can be either cumulative (paid at maturity) or periodic (monthly/quarterly/half-yearly/yearly depending on the bank's terms). However, it should be noted that very few banks offer interest rates on fixed deposits above 8%, with the exception of a few small finance banks. Karur Vysya Bank provides 7.25% interest to senior citizens, and Indian Overseas Bank gives 7.45%. Punjab & Sind Bank offers 7.55% to senior citizens, while Federal Bank provides 7.35% interest on FDs with a 444-day tenure. Axis Bank offers the highest FD interest rate of 7.25% to senior citizens on 5 years to 10 years tenure. HDFC Bank offers 7.1% on 18 months to less than 21 months tenure, while ICICI Bank offers 7.10% on 2 years 1 day to 10 years. YES Bank offers an FD interest rate of 7.85% on a tenure of 3 years to less than 5 tenure of SCSS investment is 5 years (extendable for 3 more years). It qualifies for a tax deduction under Section 80C (up to Rs 1.5 lakh investment). There is a maximum investment limit of Rs 30 account matures after 5 years and can be closed by submitting the prescribed application form with the passbook at the post case of death of account holder before maturity of the accountUpon the account holder's death, the deposit will earn PO Savings Account interest from the date of death. However, if the spouse is a joint holder or sole nominee, they may continue the account at the SCSS rate of interest until maturity, provided they meet SCSS eligibility requirements
Time of India
18 minutes ago
- Time of India
6 companies to go ex-dividend tomorrow. Check details and buy for last chance to qualify
Thursday, July 17, marks the record date for several prominent companies that have declared dividends for their shareholders. The record date is a key milestone for investors as it determines which shareholders are eligible to receive the declared dividend. In simple terms, a record date is the cut-off date established by a company to determine which shareholders are entitled to receive dividends, bonus shares , or other rights. Investors who hold shares in the company as of this date will be entitled to receive the dividend payout, which is typically paid out within a few weeks after the record date. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Gold Is Surging in 2025 — Smart Traders Are Already In IC Markets Learn More It is important to note that even if an investor buys the stock after the record date, they will not receive the dividend; the dividend will be credited to the shareholder who held the stock as of the record date. Among the companies that have set Thursday, July 17, as the record date are: 1. Coromandel International Live Events Final Dividend: 600% at Rs. 6 per share Special Dividend: 300% at Rs. 3 per share 2. GHCL Final Dividend: 120% at Rs. 12 per share 3. Graphite India Final Dividend: 550% at Rs. 11 per share 4. Oriental Hotels Final Dividend: 50% at Rs. 0.5 per share 5. PDS Ltd Final Dividend: 85% at Rs. 1.7 per share Dividends are a way for companies to distribute a portion of their earnings to shareholders. This distribution typically comes in the form of cash or additional shares, known as stock dividends. Dividends are often paid out by companies that have stable earnings and are seeking to reward their investors for their continued support. The dividend payout serves as an incentive for investors to hold on to their shares, as it provides a steady stream of income in addition to any potential capital appreciation. The dividend percentages mentioned reflect the value shareholders will receive relative to the nominal value or face value of the shares. For instance, a dividend of 600% means that for every share, a shareholder will receive Rs. 6, which is 600% of the nominal face value of the share. These dividend announcements are part of the companies' efforts to reward their investors for holding on to their shares. Investors are advised to keep track of the record dates, as they are essential for ensuring eligibility for the dividend payouts. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
NDTV
20 minutes ago
- NDTV
"If You Live In Beijing Or Delhi...": NATO Chief's Warning Over Russia Trade
WASHINGTON: NATO Secretary General Mark Rutte warned on Wednesday that countries such as Brazil, China and India could be hit very hard by secondary sanctions if they continued to do business with Russia. Rutte made the comment while meeting with senators in the US Congress the day after President Donald Trump announced new weapons for Ukraine and threatened "biting" secondary tariffs of 100% on the buyers of Russian exports unless there is a peace deal in 50 days. "My encouragement to these three countries, particularly is, if you live now in Beijing, or in Delhi, or you are the president of Brazil, you might want to take a look into this, because this might hit you very hard," Rutte told reporters, who met with Trump on Monday and agreed the new steps. "So please make the phone call to Vladimir Putin and tell him that he has to get serious about peace talks, because otherwise this will slam back on Brazil, on India and on China in a massive way," Rutte added. Republican US Senator Thom Tillis praised Trump for announcing the steps, but said the 50-day delay "worries" him. He said he was concerned that "Putin would try to use the 50 days to win the war, or to be better positioned to negotiate a peace agreement after having murdered and potentially collected more ground as a basis for negotiation. "So we should look at the current state of Ukraine today and say, no matter what you do over the next 50 days, any of your gains are off the table," he added. Rutte said Europe would find the money to ensure Ukraine was in the best possible position in peace talks. He said that under the agreement with Trump, the U.S. would now "massively" supply Ukraine with weapons "not just air defense, also missiles, also ammunition paid for by the Europeans." Asked if long-range missiles for Ukraine were under discussion, Rutte said: "It is both defensive and offensive. So there's all kinds of weapons, but we have not discussed in detail yesterday with the president. This is really being worked through now by the Pentagon, by the Supreme Allied Commander in Europe, together with the Ukrainians." (Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
